Search
Austin, TX Paid Clinical Trials
A listing of 639 clinical trials in Austin, TX actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
625 - 636 of 639
There are currently 639 clinical trials in Austin, Texas looking for participants to engage in research studies. Trials are conducted at various facilities, including GSK Investigational Site, Dell Childrens Medical Center of Central Texas, Pfizer Investigational Site and University of Texas at Austin. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Type 2 Diabetes Clinical Trial
Recruiting
Can changing your breakfast improve your type 2 diabetes? If you have an HbA1C of 7.0% or higher, you are invited to participate in an online study at the University of Michigan.
Conditions:
Type 2 Diabetes
Diabetes Mellitus Type 2 in Obese
Diabetes Type Two
Type 2 Diabetes Mellitus
Diabete Type 2
Featured Trial
Crohn's Disease Clinical Study
Recruiting
Help us study a potential new way to treat Crohn's disease. We are seeking adults living with Crohn's disease to join our latest clinical trial to help us learn more. Eligible participants will receive study-related treatment, assessments, and care at no cost. You will also receive reimbursement for travel while participating. Health insurance is not required to take part.
Conditions:
Crohn's Disease
Crohn Disease
Crohns Disease
Crohn's Disease (CD)
Crohn Colitis
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with CareGLP to offer trusted access to GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
Featured Trial
Depressive disorder Clinical Study
Recruiting
A clinical study for people that suffer with Depressive disorder
Conditions:
Depressive disorder
Improving Therapeutic Learning for PTSD
Recruiting
The proposed project seeks to demonstrate the engagement of post-exposure dopamine neurotransmission and downstream acute reorganization of dopaminergic resting-state neural networks as a means of increasing consolidation of extinction memories formed during analogue exposure therapy in adult women with PTSD. Participants will include 120 women aged 21-50 with a current diagnosis of PTSD related to physical or sexual assault, English speaking, and medically healthy. Participants will complete th... Read More
Gender:
FEMALE
Ages:
Between 21 years and 50 years
Trial Updated:
08/29/2023
Locations: University of Texas, Austin, Texas
Conditions: PTSD, Post Traumatic Stress Disorder
OSTEOAMP Lumbar Fusion Intra-Patient Controlled Study
Recruiting
The objective of this clinical study is to compare OSTEOAMP SELECT Fibers to Infuse Bone Graft, in terms of effectiveness and safety, when used as a bone graft substitute in in skeletally mature patients qualified for 2-lumbar interbody fusion (LIF) by means of an intra-patient control model.
Gender:
ALL
Ages:
Between 21 years and 80 years
Trial Updated:
08/25/2023
Locations: Austin Neurosurgeons, Austin, Texas
Conditions: Lumbar Spine Disease, Lumbar Spondylolisthesis, Lumbar Spine Instability, Lumbar Spondylosis, Degenerative Disc Disease
Dose Regimen Study of SLI-F06 in Healthy Volunteers
Recruiting
Multi-center, dose-regimen, double-blind study evaluating the safety and efficacy of 4 doses of SLI-F06 compared with vehicle for improvement in scar appearance
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
07/24/2023
Locations: DermResearch, Austin, Texas
Conditions: Scar, Wound Healing
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
Recruiting
Difficulties with speech and language are the first and most notable symptoms of primary progressive aphasia (PPA). While there is evidence that demonstrates positive effects of speech-language treatment for individuals with PPA who only speak one language (monolinguals), there is a significant need for investigating the effects of treatment that is optimized for bilingual speakers with PPA. This stage 2 efficacy clinical trial seeks to establish the effects of culturally and linguistically tail... Read More
Gender:
ALL
Ages:
40 years and above
Trial Updated:
06/28/2023
Locations: University of Texas at Austin, Austin, Texas
Conditions: Primary Progressive Aphasia, Dementia, Dementia, Frontotemporal, Alzheimer Disease, Neurodegenerative Diseases, Frontotemporal Lobar Degeneration, Apraxia, Motor, Dysarthria, Communication Disorders, Language Disorders, Speech Disorders, Neurocognitive Disorders, Aphasia, Bilingual Aphasia
Exploring the Nature, Assessment and Treatment of Stuttering
Recruiting
The purposes of this study are to 1) investigate potential speech, language, and psychosocial contributions to the experience of stuttering in monolingual and multilingual speakers, and to 2) evaluate interdisciplinary, telehealth, and speech-language pathology treatment methods and clinical training specific to fluency disorders.
Gender:
ALL
Ages:
Between 2 years and 85 years
Trial Updated:
06/20/2023
Locations: Arthur M. Blank Center for Stuttering Education and Research, Austin, Texas
Conditions: Stuttering, Stuttering, Adult, Stuttering, Childhood, Stuttering, Developmental
Implementing a Church-based Parenting Intervention for Hispanics
Recruiting
The current investigation consists of the implementation and modest refinements of a culturally adapted version of the evidence-based PT intervention known as GenerationPMTO.© The adapted intervention, CAPAS-Youth, is primarily delivered to parents. The primary research objectives are twofold: a) to conduct refinements of the CAPAS-Youth intervention for Hispanic immigrants in mid-Texas, and b) to measure implementation barriers and precursors, as well as implementation outcomes, in an effort to... Read More
Gender:
ALL
Ages:
12 years and above
Trial Updated:
06/14/2023
Locations: Steve Hicks School of Social Work, the University of Texas at Austin, Austin, Texas
Conditions: Adolescent Behavior, Parenting
Impact of Customized Respiratory Training on Cardiopulmonary Function in Parkison's Disease
Recruiting
People with PD have lower cardiopulmonary function than their age matched peers. This decline can further impair a person's ability to participate in exercise and daily activities.
Furthermore, the limitations in cardiopulmonary function can have a severe impact on mortality. There is evidence indicating the positive changes IMT can have on cardiopulmonary function in people with PD. Through intensive daily exercise people with PD have shown improvements in maximum inspiratory pressure and maxi... Read More
Gender:
ALL
Ages:
Between 30 years and 99 years
Trial Updated:
05/08/2023
Locations: University of St. Augustine for Health Sciences, Austin, Texas
Conditions: Parkinson Disease
Seaweed-derived Rhamnan Sulfate and Vascular Function
Recruiting
The primary aim of the proposed investigation is to examine the hypothesis that a relatively short period of rhamnan sulfate supplementation would improve key markers of vascular dysfunction in middle-aged and older adults with at least one risk factors for cardiovascular disease.
Gender:
ALL
Ages:
Between 35 years and 85 years
Trial Updated:
05/08/2023
Locations: Cardiovascular Aging Research Lab at UT Austin, Austin, Texas
Conditions: Cardiovascular Diseases
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
Recruiting
This is a randomized, double-blind, two-treatment, single-period, parallel design, multiple dose at multiple clinical trial sites designed to demonstrate bioequivalence with clinical endpoint in subjects with chronic open-angle glaucoma or ocular hypertension in both eyes.
Test Product - Bimatoprost ophthalmic solution, 0.01% of Amneal EU, Limited Reference Product - LUMIGAN® (bimatoprost ophthalmic solution) 0.01% of Allergan, Inc.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/09/2022
Locations: Keystone Research, Austin, Texas
Conditions: Glaucoma, Open-Angle, Ocular Hypertension
A Study in Patients With Advanced Cancers
Recruiting
A first-in-human study using BIO-106 as a single agent and in combination with pembrolizumab in advanced cancers.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/15/2022
Locations: NEXT Oncology Austin, Austin, Texas
Conditions: Advanced Cancer, Advanced Solid Tumor, Cancer, Oncology
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
Recruiting
Nighttime agitation in persons with Alzheimer's disease causes patient suffering, distresses caregivers, and often results in prescriptions for harmful antipsychotics. Effective treatments are lacking because of limited knowledge of the etiology of nighttime agitation. The investigators propose a clinical trial to better elucidate whether a sleep disorder, restless legs syndrome, may be a mechanism for nighttime agitation, and if treatment with gabapentin enacarbil (Horizant®) reduces nighttime... Read More
Gender:
ALL
Ages:
55 years and above
Trial Updated:
05/16/2022
Locations: The University of Texas at Austin, Austin, Texas
Conditions: Alzheimer Disease
Neuroimaging Memories of Fear and Safety in the Human Brain
Recruiting
The purpose of this research is to use functional magnetic resonance imaging (fMRI) to investigate how the brain forms associations between neutral and negative stimuli. The ultimate goal is to understand the neural systems involved in regulating negative emotional responses to fearful stimuli.
Gender:
ALL
Ages:
Between 18 years and 50 years
Trial Updated:
05/16/2022
Locations: The University of Texas at Austin, Austin, Texas +1 locations
Conditions: Fear Anxiety, PTSD
625 - 636 of 639